1. Empliciti (elotuzumab)
    Empliciti (elotuzumab)
    by Bristol-Myers Squibb
    for Multiple Myeloma
  2. Fycompa (perampanel)
    Fycompa (perampanel)
    by Eisai Europe Ltd
    for Epilepsy
  3. Ibrance (palbociclib)
    Ibrance (palbociclib)
    by Pfizer Limited
    for Breast Cancer
  4. Imfinzi (durvalumab)
    Imfinzi (durvalumab)
    by AstraZeneca Pharmaceuticals LP
    for Urothelial Carcinoma, Lung Cancer
  5. Kevzara (sarilumab)
    Kevzara (sarilumab)
    by Sanofi - Aventis Groupe
    for Rheumatoid Arthritis
  6. Keytruda (pembrolizumab)
    Keytruda (pembrolizumab)
    by Merck Sharp
    for Urothelial Carcinoma, Gastric Cancer, Head and Neck Cancer, Lung Cancer, Lymphoma, Skin Cancer
  7. Kisqali (ribociclib)
    Kisqali (ribociclib)
    by Novartis Europharm Limited
    for Breast Cancer
  8. Lartruvo (olaratumab)
    Lartruvo (olaratumab)
    by Eli Lilly Nederland B.V.
    for Soft Tissue Sarcoma
View as Grid List

Items 28-36 of 62

per page
Set Descending Direction